204 related articles for article (PubMed ID: 35931978)
1. High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa.
Tiiti TA; Selabe SG; Bogers J; Lebelo RL
BMC Cancer; 2022 Aug; 22(1):854. PubMed ID: 35931978
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa.
Tiiti TA; Mashishi TL; Nkwinika VV; Molefi KA; Benoy I; Bogers J; Selabe SG; Lebelo RL
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768334
[TBL] [Abstract][Full Text] [Related]
6. Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection.
Huang J; Yin C; Wang J
J Obstet Gynaecol; 2023 Dec; 43(1):2161349. PubMed ID: 36645341
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
Fan Y; Shen Z
Pathol Res Pract; 2018 May; 214(5):767-775. PubMed ID: 29655523
[TBL] [Abstract][Full Text] [Related]
8. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
9. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
11. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
Wang HY; Kim H; Park KH
Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
[No Abstract] [Full Text] [Related]
15. Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression.
Chuery ACS; Silva IDCGD; Ribalta JCL; Speck NMG
Braz J Infect Dis; 2017; 21(3):248-254. PubMed ID: 28347732
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
Cattani P; Zannoni GF; Ricci C; D'Onghia S; Trivellizzi IN; Di Franco A; Vellone VG; Durante M; Fadda G; Scambia G; Capelli G; De Vincenzo R
J Clin Microbiol; 2009 Dec; 47(12):3895-901. PubMed ID: 19828739
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
[TBL] [Abstract][Full Text] [Related]
19. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
Coquillard G; Palao B; Patterson BK
Gynecol Oncol; 2011 Jan; 120(1):89-93. PubMed ID: 20950847
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
